Resources
Filter by Topic
- News & Events
Podium and poster to be presented at 2021 Virtual ISPOR, May 17th - 20th.
- Articles
Scientific American article by Panalgo CEO, Joseph Menzin, PhD, and Panalgo Strategic Advisory Board member, Peter Neumann, ScD.
- Blogs
By David Kreutter, PhD
- Blogs
Q&A with Vijay Raghavan, Associate Vice President, Market Analytics and Business Insights, AbbVie
- Press Releases
Report examines the drivers, barriers, and benefits of using real-world data (RWD) and advanced analytics
- Publication
Authors: Nina Shah, Matthew Sussman, Concetta Crivera, Satish Valluri, Jennifer Benner & Sundar Jagannath Published: Clinical Drug Investigation Click here to view the article.
- Press Releases
Panalgo’s IHD software to be used by the EMA to rapidly answer questions around drug safety and efficacy and better understand real-world medication use.
The Importance of Accounting for Time-Related Bias in Single-Arm Trials with Historical Controls (Part 2)
In our previous blog post, we sat down with Dr. Samy Suissa, the co-founder and principal investigator of the Canadian Network for Observational Drug Effect Studies,
IHD Analytics
Put reliable, rapid analytics in the hands of more people across your organization